Literature DB >> 7527500

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

E M Beckman1, S A Porcelli, C T Morita, S M Behar, S T Furlong, M B Brenner.   

Abstract

Major histocompatibility complex (MHC) class I and class II molecules bind immunogenic peptides and present them to lymphocytes bearing the alpha beta T-cell antigen receptor (TCR). An analogous antigen-presenting function also has been proposed for the non-MHC-encoded CD1 molecules, a family of non-polymorphic, beta 2-microglobulin-associated glycoproteins expressed on most professional antigen-presenting cells. In support of this hypothesis, CD1 molecules are recognized by selected CD4-CD8- alpha beta or gamma delta TCR+ T-cell clones, and we have recently shown that CD1 molecules restrict the recognition of foreign microbial antigens by alpha beta TCR+ T cells. But the substantial structural divergence of CD1 from MHC class I and class II molecules, raises the possibility that the antigens presented by the CD1 system may differ fundamentally from those presented by MHC-encoded molecules. Here we report that a purified CD1b-restricted antigen of Mycobacterium tuberculosis presented to alpha beta TCR+ T cells is mycolic acid, a family of alpha-branched, beta-hydroxy, long-chain fatty acids found in mycobacteria. This example of non-protein microbial antigen recognition suggests that alpha beta TCR+ T cells recognize a broader range of antigens than previously appreciated and that at least one member of the CD1 family has evolved the ability to present lipid antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527500     DOI: 10.1038/372691a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  291 in total

1.  Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus.

Authors:  Y Dang; J Beckers; C R Wang; K D Heyborne
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

Review 2.  The cells that knew too much.

Authors:  A G Baxter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 4.  Right on target: novel approaches for the direct visualization of CD1-specific T cell responses.

Authors:  M Kronenberg; O Naidenko; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 5.  Dendritic cells: immune saviors or Achilles' heel?

Authors:  C W Cutler; R Jotwani; B Pulendran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

7.  NK T cells are a source of early interleukin-4 following infection with third-stage larvae of the filarial nematode Brugia pahangi.

Authors:  Paul Balmer; Eileen Devaney
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 8.  Allergic reactions to drugs: involvement of T cells.

Authors:  W J Pichler; N Yawalkar
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 9.  A new aspect in glycolipid biology: glycosphingolipids as antigens recognized by T lymphocytes.

Authors:  G De Libero; A Donda; H J Gober; V Manolova; Z Mazorra; A Shamshiev; L Mori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

10.  Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire.

Authors:  M Mempel; B Flageul; F Suarez; C Ronet; L Dubertret; P Kourilsky; G Gachelin; P Musette
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.